The risk of abdominal obesity according to the degree of non- alcoholic fatty liver disease in Korean men

Journal of Korean Medical Science

Volumn 31, Issue 3, 2016, Pages 410-416

  Park, Sung Keun ^a,b   Ryoo, Jae Hong ^b   Choi, Joong Myung ^b   Seo, Min Woo ^b   Park, Chung Min ^b  

^a School of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Abdominal; Non alcoholic fatty liver disease; Obesity; Waist circumference

Indexed keywords

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT ANALYSIS; COMPLICATION; DEMOGRAPHY; FOLLOW UP; HUMAN; INCIDENCE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, ABDOMINAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SOUTH KOREA; WAIST CIRCUMFERENCE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DEMOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, ABDOMINAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84960453055     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2016.31.3.410     Document Type: Article

References (26)

1. World Health Organization. Obesity and overweight. Available at http://www.who.int/mediacentre/factsheets/fs311/en/index.html [accessed on 1 June 2014].
2. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008;32:1431-7.
3. Coutinho T, Goel K, Corrêa de Sá D, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, Torp-Pedersen C, Cottin Y, et al. Central obesity and survival in subjects with coronary artery disease:a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011;57:1877-86.
4. Anjana M, Sandeep S, Deepa R, Vimaleswaran KS, Farooq S, Mohan V. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care 2004;27:2948-53.
5. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-7.
6. Højgaard B, Olsen KR, Søgaard J, Sørensen TI, Gyrd-Hansen D. Economic costs of abdominal obesity. Obes Facts 2008;1:146-54.
7. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
8. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-19.
9. Ryoo JH, Choi JM, Moon SY, Suh YJ, Shin JY, Shin HC, Park SK. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men:5-year's prospective cohort study. Atherosclerosis 2013;227:398-403.
10. Nishiura T, Watanabe H, Ito M, Matsuoka Y, Yano K, Daikoku M, Yatsuhashi H, Dohmen K, Ishibashi H. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. Br J Radiol 2005;78:189-97.
11. Hung CH, Lu SN, Wang JH, Lee CM, Chen TM, Tung HD, Chen CH, Huang WS, Changchien CS. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J Gastroenterol 2003;38:153-7.
12. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-50.
13. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM, Cooper JN, Sheridan MJ. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver:a meta-analysis. Hepatology 2011;54:1082-90.
14. Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, Repetto G. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004;14:635-7.
15. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, et al. Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;National Heart, Lung, and Blood Institute;American Heart Association;World Heart Federation;International Atherosclerosis Society;and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
16. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003;124:71-9.
17. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome:further evidence for an etiologic association. Hepatology 2002;35:367-72.
18. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis:association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-92.
19. Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, Hu X, Botezelli JD, Asadi A, Hoffman BG, Kieffer TJ, et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab 2012;16:723-37.
20. McNay EC, Teske JA, Kotz CM, Dunn-Meynell A, Levin BE, McCrimmon RJ, Sherwin RS. Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance:a model for weight gain with intensive insulin therapy. Am J Physiol Endocrinol Metab 2013;304:E131-8.
21. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes-causes, effects and coping strategies. Diabetes Obes Metab 2007;9:799-812.
22. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease:the Dionysos nutrition and liver study. Hepatology 2005;42:44-52.
23. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease:is biopsy necessary? Eur J Gastroenterol Hepatol 2003;15:539-43.
24. Mathiesen UL, Franzén LE, Aselius H, Resjö M, Jacobsson L, Foberg U, Frydén A, Bodemar G. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002;34:516-22.
25. Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver:ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984;3:9-14.
26. Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, Gilat T, Weiss J, Walach E, Amazeen P, et al. Quantitative estimation of attenuation in ultrasound video images:correlation with histology in diffuse liver disease. Invest Radiol 2000;35:319-24.